Division of Nuclear Medicine, Campinas State University (UNICAMP), Campinas, Brazil.
Department of Otorhinolaringology, Campinas State University (UNICAMP), Campinas, Brazil.
JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):834-41. doi: 10.1001/jamaoto.2016.1227.
Single-photon emission computed tomography/computed tomography (SPECT/CT) and radioguided sentinel lymph node biopsy (rSLNB) are techniques that could potentially benefit surgeons and pathologists in the identification of sentinel lymph node (SLN) metastases in patients with papillary thyroid carcinoma (PTC). Evidence suggests that these novel techniques lead to substantial changes in PTC management by reducing understaging and of occult lymph node (LN) metastases and optimizing neck surgery by increasing the necessity of lateral lymphadenectomy and decreasing central lymphadenectomy.
To correlate the presence of LN metastases in PTC with clinical and pathological features using SPECT/CT and rSLNB.
DESIGN, SETTING, AND PARTICIPANTS: For this prospective cohort study from June 2010 to November 2013, 42 patients with thyroid nodules suspicious for papillary carcinoma or classified as malignant on cytology examination without suspicion of lymph node metastases by clinical and ultrasound examinations were recruited from a single public medical institution.
All 42 patients underwent preoperative lymphoscintigraphy after an ultrasound-guided peritumoral injection of Technetium Tc 99m nanocolloid. Cervical images were acquired with a SPECT/CT scanner 15 minutes after radiotracer injection. Approximately 2 hours after lymphoscintigraphy, the patients were submitted to intraoperative rSLNB using a handheld gamma probe. All SLNs identified were removed alongside with non-SLNs from the same compartment. Papillary thyroid carcinoma, SLNs and non-SLNs were submitted for histopathology and immunohistochemical analyses.
Of the 42 patients initially enrolled, 37 were included in analysis, including 6 men and 31 women with a mean (range) age of 47 (22-83) years. Overall, T stage was as follows: T1, 23 patients (62.2%); T2, 8 patients (21.6%); and T3, 6 patients (16.2%). Sentinel lymph nodes were identified in 92% of the patients, and among these metastases were present in 17 patients (46%). The SLNs were false-negative in 3 patients. Metastases in the lateral compartment ocurred in 7 patients (18%). There was a significant association between LN metastases and tumor size (odds ratio, 1.06; 95% CI, 1.00-1.13; P = .02), with a Cohen d effect of 0.683 (medium to large effect). Overall, 17 patients (46%) with LN metastases had management changed because they were submitted to higher radioiodine ablation doses and closer clinical surveillance.
Radioguided SLNB is able to detect occult cervical lymph node metastases in patients with papillary thyroid carcinoma, and in 7 patients (18%) rSLNB detected lymph node metastases in the lateral compartments. The rSLNB technique lead to management change in 14 patients (37.8%).
单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)和放射性示踪剂引导的前哨淋巴结活检(rSLNB)是可以帮助外科医生和病理学家识别甲状腺乳头状癌(PTC)患者前哨淋巴结(SLN)转移的技术。有证据表明,这些新的技术通过减少分期不足和隐匿性淋巴结(LN)转移,以及通过增加侧方淋巴结清扫术的必要性和减少中央淋巴结清扫术,极大地改变了 PTC 的治疗方式。
使用 SPECT/CT 和 rSLNB 检测 PTC 中 LN 转移与临床和病理特征的相关性。
设计、地点和参与者:这是一项从 2010 年 6 月至 2013 年 11 月进行的前瞻性队列研究,从一家公立医院招募了 42 名甲状腺结节疑似甲状腺癌或细胞学检查为恶性但临床和超声检查未怀疑淋巴结转移的患者。
所有 42 例患者均在超声引导下肿瘤周围注射锝 Tc 99m 纳米胶体后进行术前淋巴闪烁显像。放射性示踪剂注射后 15 分钟,使用 SPECT/CT 扫描仪采集颈部图像。淋巴闪烁显像后约 2 小时,使用手持式伽马探针进行术中 rSLNB。所有识别出的 SLN 与来自同一部位的非 SLN 一起切除。对甲状腺乳头状癌、SLN 和非 SLN 进行组织病理学和免疫组织化学分析。
最初纳入的 42 名患者中,有 37 名患者被纳入分析,包括 6 名男性和 31 名女性,平均(范围)年龄为 47(22-83)岁。总体而言,T 分期如下:T1 期,23 例(62.2%);T2 期,8 例(21.6%);T3 期,6 例(16.2%)。92%的患者识别出了 SLN,其中 17 例(46%)存在转移。3 例 SLN 呈假阴性。7 例(18%)患者发生侧方淋巴结转移。LN 转移与肿瘤大小之间存在显著相关性(比值比,1.06;95%CI,1.00-1.13;P = .02),Cohen d 效应值为 0.683(中到大效应)。总的来说,17 名(46%)有 LN 转移的患者由于接受了更高剂量的放射性碘消融和更密切的临床监测而改变了治疗方案。
放射性示踪剂引导的 SLNB 能够检测甲状腺乳头状癌患者隐匿性颈淋巴结转移,在 7 例(18%)患者中 rSLNB 检测到侧方淋巴结转移。rSLNB 技术使 14 例(37.8%)患者的治疗方案发生改变。